aap reports profitable Q1 2012 sales growth of 51% to EUR 9.9 million; Increased sales forecast for the financial year 2012 to EUR 34 million (+16%)

aap: 51% sales increase to EUR 9.8 million in the first quarter 2012

aap annual financial statements for 2011: 6% sales growth at product level with strong EBITDA/EBIT increase; successful launch of the LOQTEQ® system

aap Implantate AG Licenses Proprietary Biomaterials Product to a World Leading Medical Technology Company

aap signs exclusive license agreement for an IP-protected product of its biomaterial portfolio

aap’s full year 2011 sales on product-level totalled EUR 29.2 million (+6%) and Q4 sales increased by 9% to EUR 8.2 million